Literature DB >> 15459803

Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta.

Erika Shimomura1, Mitsuya Shiraishi, Takahiro Iwanaga, Minoru Seto, Yasuharu Sasaki, Masahiro Ikeda, Katsuaki Ito.   

Abstract

Protein kinase C (PKC) activation by a phorbol ester increases myosin light chain (MLC(20)) phosphorylation through inhibition of MLC phosphatase (MLCP) and enhances contraction of vascular smooth muscle. We investigated whether Rho kinase, which is known to inhibit MLCP, is involved in the MLC(20) phosphorylation caused by a phorbol ester, 12-deoxyphorbol 13-isobutyrate (DPB), in rabbit aortas. DPB (1 microM) increased MLC(20) phosphorylation and tension. The Rho kinase inhibitor fasudil (10 microM) inhibited the DPB-induced contraction and decreased the MLC(20) phosphorylation at Ser19, a site phosphorylated by MLC kinase, although it did not affect the phosphorylation of total MLC(20). Rinsing a 65.4 mM KCl-contracted aorta with Ca(2+)-free, EGTA solution caused rapid dephosphorylation of MLC(20) and relaxation. When DPB was present in the rinsing solution, the MLC(20) dephosphorylation and the relaxation were inhibited. In this protocol, Ro31-8220 (10 microM), a PKC inhibitor, suppressed the phosphorylation of total MLC(20) and Ser19 induced by DPB. Fasudil also inhibited the Ser19 phosphorylation to a degree similar to Ro31-8220 and accelerated relaxation, which was less than the relaxation caused by Ro31-8220. The phospholipase A(2) inhibitor ONO-RS-082 (5 microM) inhibited the DPB-induced Ser19 phosphorylation but only transiently decreased the tension, suggesting the involvement of arachidonic acid in the phosphorylation and the existence of a MLC(20) phosphorylation-independent mechanism. When fasudil was combined with ONO-RS-082, fasudil exerted additional inhibition of the tension without further inhibition of the Ser19 phosphorylation. DPB phosphorylated the 130 kDa myosin binding subunit (MBS) of MLCP and fasudil inhibited the phosphorylation. These data suggest that the inhibition by fasudil of DPB-induced contraction and phosphorylation of MLC(20) at the MLC kinase-targeted site is a result of inhibition of Rho kinase. Thus, the PKC-dependent Ca(2+)-sensitization of vascular smooth muscle involves Rho kinase. A MLC(20) phosphorylation-independent mechanism is also involved in the Ca(2+)-sensitization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459803     DOI: 10.1007/s00210-004-0975-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  41 in total

1.  Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium.

Authors:  M C Gong; A Fuglsang; D Alessi; S Kobayashi; P Cohen; A V Somlyo; A P Somlyo
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

Review 2.  Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems.

Authors:  K Sobue; J R Sellers
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

3.  Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase.

Authors:  K Nakamura; J Nishimura; K Hirano; S Ibayashi; M Fujishima; H Kanaide
Journal:  J Cereb Blood Flow Metab       Date:  2001-07       Impact factor: 6.200

4.  Stimulus-specific patterns of myosin light chain phosphorylation in smooth muscle of rabbit thoracic artery.

Authors:  M Seto; Y Sasaki; Y Sasaki
Journal:  Pflugers Arch       Date:  1990-01       Impact factor: 3.657

5.  Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase. Phosphorylation sites and effects of phosphorylation.

Authors:  M Ikebe; D J Hartshorne; M Elzinga
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

6.  Selectivity of action of staurosporine on Ca2+ movements and contractions in vascular smooth muscles.

Authors:  M Asano; K Matsunaga; M Miura; K M Ito; M Seto; K Sakurada; H Nagumo; Y Sasaki; K Ito
Journal:  Eur J Pharmacol       Date:  1995-12-29       Impact factor: 4.432

7.  Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation.

Authors:  S J Winder; M P Walsh
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

8.  Rho-associated kinase of chicken gizzard smooth muscle.

Authors:  J Feng; M Ito; Y Kureishi; K Ichikawa; M Amano; N Isaka; K Okawa; A Iwamatsu; K Kaibuchi; D J Hartshorne; T Nakano
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

Review 9.  Myosin light chain phosphatase: subunit composition, interactions and regulation.

Authors:  D J Hartshorne; M Ito; F Erdödi
Journal:  J Muscle Res Cell Motil       Date:  1998-05       Impact factor: 2.698

10.  A novel mechanism for the Ca(2+)-sensitizing effect of protein kinase C on vascular smooth muscle: inhibition of myosin light chain phosphatase.

Authors:  M Masuo; S Reardon; M Ikebe; T Kitazawa
Journal:  J Gen Physiol       Date:  1994-08       Impact factor: 4.086

View more
  3 in total

1.  Kinase-dependent activation of voltage-gated Ca2+ channels by ET-1 in pulmonary arterial myocytes during chronic hypoxia.

Authors:  Trevor Luke; Julie Maylor; Clark Undem; J T Sylvester; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-02       Impact factor: 5.464

2.  Burn-Induced Impairment of Ileal Muscle Contractility Is Associated with Increased Extracellular Matrix Components.

Authors:  Claire B Cummins; Yanping Gu; Xiaofu Wang; You-Min Lin; Xuan-Zheng Shi; Ravi S Radhakrishnan
Journal:  J Gastrointest Surg       Date:  2019-10-21       Impact factor: 3.452

3.  Human Galectin-7 Gene LGALS7 Promoter Sequence Polymorphisms and Risk of Spontaneous Intracerebral Hemorrhage: A Prospective Study.

Authors:  Ming-Dong Wang; Jing Tian; John H Zhang; Shun-Ying Zhao; Ming-Jing Song; Zhan-Xiang Wang
Journal:  Front Mol Neurosci       Date:  2022-03-23       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.